Volume 89 Issue 3 | pp. 28-29
Issue Date: January 17, 2011

Consumer Protection: Expect Action On Product, Drug Safety

Department: Government & Policy
Keywords: Drug Safety, Drug Safety & Accountability Act, Congress

Growing concerns about the quality and safety of prescription drugs will likely trigger hearings in both the House and the Senate this year. Leaders in both chambers have pledged to overhaul drug safety policies at the Food & Drug Administration.

“We need better protections against unsafe drugs and stronger oversight of the entire drug supply chain,” Sen. Tom Harkin (D-Iowa), chairman of the Health, Education, Labor & Pensions Committee, said in a joint . . .

To view the rest of this content, please log in with your ACS ID.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society